The development of more cost-effective formulations and manufacturing techniques may alleviate existing accessibility issues
Disclosures: Cynthia Levy: Cymabay: Grant/Research Support, Cymabay: Consultant, Intercept: Grant/Research Support, Intercept: Consultant, Calliditas: Grant/Research Support, Calliditas: Consultant, GSK: Consultant, GSK: Grant/Research Support, Ipsen: Grant/Research Support, Ipsen: Consultant, Mirum: Grant/Research Support, Mirum: Consultant, Zydus: Grant/Research Support, Gilead: Grant/Research Support, Gilead: Consultant, Escient: Grant/Research Support, Kowa: Grant/Research Support, Kowa: Consultant, Genfit: Grant/Research Support, COur: Advisor, Chemomab: Consultant, Christopher Bowlus: Calliditas: Grant/Research Support, ChemoMab: Grant/Research Support, ChemoMab: Consultant, COUR Phamaceuticals: Grant/Research Support, Cymabay: Grant/Research Support, Cymabay: Consultant, Cymabay: Consultant, Gilead: Grant/Research Support, GSK Pharmaceuticals: Grant/Research Support, GSK Pharmaceuticals: Consultant, Hanmi: Grant/Research Support, Intercept: Grant/Research Support, Invea Therapeutics: Consultant, Ipsen: Grant/Research Support, Ipsen: Consultant, Mirum: Grant/Research Support, NGM Bio: Consultant, Novartis: Grant/Research Support, Novo Nordisk: Grant/Research Support, Pliant Therapeutics: Grant/Research Support, Pliant Therapeutics: Consultant, Viking Therapeutics: Grant/Research Support, Zydus Therapeutics: Grant/Research Support, Eric Lawitz: Nothing to Disclose, Nuno Antunes: Nothing to Disclose, Benjamin Miller: Ipsen: Employee, Ipsen: Stock - publicly traded company, Jianfen Shu: Nothing to Disclose, Claudia Zein: Ipsen: Employee, Kris Kowdley: Nothing to Disclose 2346 TREATMENT RESPONSE IN PRIMARY BILIARY CHOLANGITIS BASED ON DIFFERING CRITERIA Ana Maria Davila Morales 1 Kesany Boupapanh 1 Zoe Post 1 Nancy Reau 1 , 1 Rush University Medical Center Background: Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease commonly associated with women aged 40 or older, high levels of alkaline phosphatase (ALP), and antimitochondrial autoantibodies (AMA)
Were not here to scare you or food-shame
We serve all of Pasadena and nearby areas, and our clinic meets all local and state health standards for medical weight loss services
32.9%), dulaglutide (Trulicity
